BAKER BROS. ADVISORS LP – TCR2 Therapeutics Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$1.35M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-37.93%
quarter
TCR2 Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -828K | $1.8 | 753.06K | |
| Q2 2022 | share | 0.00% | 0 shares | 106K | $2.9 | 753.06K | |
| Q1 2022 | share | 0.00% | 0 shares | -1.43M | $2.76 | 753.06K | |
| Q4 2021 | share | Increase | +326.76% | 576.60K shares | 2.00M | $4.79 | 753.06K |
| Q3 2021 | share | 0.00% | 0 shares | -1.39M | $8.51 | 176.46K | |
| Q2 2021 | share | 0.00% | 0 shares | -1M | $16.41 | 176.46K | |
| Q1 2021 | share | Increase | +59.13% | 65.57K shares | 466K | $22.08 | 176.46K |
| Q4 2020 | share | Decrease | -9.50% | -11.64K shares | 940K | $30.93 | 110.88K |
| Q3 2020 | share | Increase | 0.00% | 122.53K shares | 2.49M | $20.32 | 122.53K |